You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
心通醫療-B(02160.HK):自研經導管二尖瓣置換系統多例人體植入隨訪結果優異
格隆匯 08-06 18:15

格隆匯8月6日丨心通醫療-B(02160.HK)發佈公吿,集團自主研發的經導管二尖瓣置換系統(“經導管二尖瓣置換系統”)正推進臨牀應用,並已成功用於救治多名重度二尖瓣反流(“二尖瓣反流”)患者,其中首例患者於近日順利完成一年隨訪,其餘患者的三個月、一個月隨訪結果亦令人振奮,均實現二尖瓣反流顯着降低、無反覆,無瓣周漏,無左室流出道梗阻,心功能相關指標明顯改善,患者自述二尖瓣反流引起的不適症狀明顯好轉。我們的經導管二尖瓣置換系統是全球首個應用於臨牀的幹瓣經導管二尖瓣置換產品,其多例成功人體應用及優異隨訪結果進一步驗證該系統的有效性及安全性,標誌着該系統的臨牀應用邁入新階段。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account